Middle East and Africa Prescription Digital Therapeutics (PDTx) Market – Industry Trends and Forecast to 2027

  • Pharmaceutical
  • Published Report
  • Dec 2020
  • MEA
  • 350 Pages
  • No of Tables: 250
  • No of Figures: 61

Middle East and Africa Prescription Digital Therapeutics (PDTx) Market, By Mechanism (Input Mechanisms and Output Mechanisms), Category (Medication Augmentation and Medication Replacement), Treatment (Outpatient Treatment and Monotherapy), Software (Software For Respiratory Conditions, Software For Mental Health, Software For Opioid Use Disorder, Software For Diabetes and Others), Services (Behavioral Microservices and Medical Microservices), App Accessibility (Android, iOS and Windows), App Type (Native Apps and Web Apps), Application (Substance Use Disorder (SUD), Opioid Use Disorder (OUD), Attention Deficit/Hyperactivity Disorder (ADHD), Alzheimer’s Disease, Major Depressive Disorder (MDD), Insomnia, Epilepsy, Movement Disorder, Multiple Sclerosis, Migraine, Autism Spectrum Disorder, Oncology, Inflammation, Respiratory, Cardiovascular, Pain Management, Metabolic Conditions and Others), Patients (Children and Adults), Country (South Africa, Saudi Arabia, U.A.E., Egypt, Kuwait, Israel and Rest of Middle East and Africa) Industry Trends and Forecast to 2027

Middle East and Africa Prescription Digital Therapeutics (PDTx) Market Market Analysis and Insights : Middle East and Africa Prescription Digital Therapeutics (PDTx) Market

Middle East and Africa prescription digital therapeutics (PDTx) market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 19.8% in the forecast period of 2020 to 2027 and is expected to reach USD 37.79 million by 2027 from USD 9.77 million in 2019.

Increasing need for effective prescription digital therapeutics (PDTx) options, rising government initiatives are the major drivers which boost the demand of the market in the forecast period.

Prescription digital therapeutics (PDTx) is medical innovation which runs through some as a main key to manage, prevent or medical disorders or disease. Prescription digital therapeutics is different from the digital therapeutics because these PDTx are approved by FDA with clinical supported data. Whereas, digital therapeutics are kind of health management app may be approved by only peer reviewed data but have lack of clinical data.

Prescription digital therapeutics (PDTx) comprises features such as increasing need for effective Treatment for chronic diseases will impact in launching of new product by the manufactures into the market which enhance its demand as well as rising pharmaceutical industries initiatives leads to the market growth. Currently, various research & clinical studies are going on which is expected to create a competitive advantage for manufacturers to develop new and innovative technology. Moreover, these clinical programmes are also expected to provide various other opportunities in the Prescription Digital Therapeutics (PDTx) market. However, lack of awareness in rural countries and high cost of therapeutics expected to restraint the market growth in the forecast period.

The prescription digital therapeutics (PDTx) market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an analyst brief, our team will help you create a revenue impact solution to achieve your desired goal.

Middle East and Africa Prescription Digital Therapeutics (PDTx) Market Middle East and Africa Prescription Digital Therapeutics (PDTx) Market Scope and Market Size

Prescription digital therapeutics (PDTx) market is segmented on the based on the basis of mechanism, category, treatment, software, services, app accessibility, app type, application, patients and country. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of mechanism, the prescription digital therapeutics (PDTx) market is segmented into input mechanism and output mechanism. In 2020, input mechanism segment is dominating the prescription digital therapeutics (PDTx) market as majority of prescription therapeutics devices are input based system.
  • On the basis of category, the digital therapeutics (PDTx) market is segmented into medication augmentation and medication replacement. In 2020, medication augmentation segment is dominating the Prescription Digital Therapeutics (PDTx) market due to medication augmentation cannot replace the treatment by medication but it enhances the effectiveness of the treatment.
  • On the basis of treatment, the prescription digital therapeutics (PDTx) market is segmented into outpatient treatment and monotherapy. In 2020, outpatient treatment segment is dominating the prescription digital therapeutics (PDTx) market due to prescription therapeutics majorly designed for the patients who cannot visit the doctor’s clinics regularly.
  • On the basis of software, the prescription digital therapeutics (PDTx) market is segmented into software for respiratory conditions, software for mental health, software for opioid use disorder, software for diabetes and others. In 2020, software for diabetes segment is dominating the prescription digital therapeutics (PDTx) market as metabolic diseases are majorly affecting the population and a serious concern for the pharmaceutical industries.
  • On the basis of services, prescription digital therapeutics (PDTx) market is segmented into behavioral microservices and medical microservices. In 2020, behavioral microservices segment is dominating the prescription digital therapeutics (PDTx) market because prescription digital therapeutics majorly work on the patients behaviors as diseases it directly connected with the patients moo.
  • On the basis of app accessibility, the prescription digital therapeutics (PDTx) market is segmented into android, iOS and windows. In 2020, android segment is dominating the prescription digital therapeutics (PDTx) market because androids are the most commonly used or accessible software at every one can handle this and majority of application run via android software.
  • On the basis of app type, the prescription digital therapeutics (PDTx) market is segmented into native apps and web apps. In 2020, native aap segment is dominating the prescription digital therapeutics (PDTx) market because native app can be downloaded or purchased via the app store, these app cannot required any other software.
  • On the basis of application, the prescription digital therapeutics (PDTx) market is segmented into substance use disorder (SUD), opioid use disorder (OUD), attention deficit/hyperactivity disorder (ADHD), alzheimer’s disease, major depressive disorder (MDD), insomnia, epilepsy, movement disorder, multiple sclerosis, migraine, autism spectrum disorder, oncology, inflammation, respiratory, cardiovascular, pain management, metabolic conditions and others. In 2020, metabolic conditions segment is dominating the prescription digital therapeutics (PDTx) market because diabetes is the most prevalent disease and requires urgent technological devices for the monitoring.
  • On the basis of patients, the prescription digital therapeutics (PDTx) market is segmented into children and adults. In 2020, adults segment is dominating the prescription digital therapeutics (PDTx) market because till now few prescription digital therapeutics supports the children data but all the applications supports the adults population data and can be used only for the adults.

Prescription Digital Therapeutics (PDTx) Market Country Level Analysis

The prescription digital therapeutics (PDTx) market is analysed and market size information is provided by the basis of mechanism, category, treatment, software, services, app accessibility, app type, application and patients.

The countries covered in the prescription digital therapeutics (PDTx) market report are South Africa, Saudi Arabia, U.A.E., Egypt, Kuwait, Israel and Rest of Middle East and Africa.

Saudi Arabia is expected to grow with the substantial growth rate in the forecast period of 2020 to 2027 in Middle East and Africa countries because of increasing awareness towards digital therapeutics and increasing investment by the market players.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Middle East and Africa brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Strategic Initiatives by Manufactures is Creating New Opportunities for Players in the Prescription Digital Therapeutics (PDTx) Market

Prescription digital therapeutics (PDTx) market also provides you with detailed market analysis for every country growth in aesthetic industry with prescription digital therapeutics (PDTx) sales, impact of advancement in the prescription digital therapeutics (PDTx) and changes in regulatory scenarios with their support for the prescription digital therapeutics (PDTx) market. The data is available for historic period 2010 to 2018.

Competitive Landscape and Prescription Digital Therapeutics (PDTx) Market Share Analysis

Prescription digital therapeutics (PDTx) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to prescription digital therapeutics (PDTx) market.

The major companies which are dealing in the prescription digital therapeutics (PDTx) are Omada ResMed, Samsung, among others domestic and Middle East and Africa players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product launch and agreement are also initiated by the companies’ worldwide which are also accelerating the prescription digital therapeutics (PDTx) market.

  • In November 2019, Welldoc Inc., announces the development and commercialization of BlueStar to East Asia with Japan based Astellas Inc.

Collaboration, joint ventures and other strategies by the market player is enhancing the company market in the prescription digital therapeutics (PDTx) market which also provides the benefit for organisation to improve their offering for prescription digital therapeutics (PDTx).

Customization Available: Middle East and Africa Prescription Digital Therapeutics (PDTx) Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

LIST OF TABLES

TABLE 1 REGULATORY FRAMEWORK

TABLE 2 MIDDLE EAST AND AFRICA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, PIPELINE ANALYSIS

TABLE 3 MIDDLE EAST AND AFRICA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM 2019-2027 (USD MILLION)

TABLE 4 MIDDLE EAST AND AFRICA INPUT MECHANISMS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 5 MIDDLE EAST AND AFRICA INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 6 MIDDLE EAST AND AFRICA PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 7 MIDDLE EAST AND AFRICA DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 8 MIDDLE EAST AND AFRICA AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 9 MIDDLE EAST AND AFRICAINPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 10 MIDDLE EAST AND AFRICA OUTPUT MECHANISMS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 11 MIDDLE EAST AND AFRICA OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 12 MIDDLE EAST AND AFRICA PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 13 MIDDLE EAST AND AFRICA ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 14 MIDDLE EAST AND AFRICA CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 15 MIDDLE EAST AND AFRICA OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 16 MIDDLE EAST AND AFRICA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY 2019-2027 (USD MILLION)

TABLE 17 MIDDLE EAST AND AFRICA MEDICATION AUGMENTATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 18 MIDDLE EAST AND AFRICA MEDICATION REPLACEMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 19 MIDDLE EAST AND AFRICA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT 2019-2027 (USD MILLION)

TABLE 20 MIDDLE EAST AND AFRICA OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 21 MIDDLE EAST AND AFRICA OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 22 MIDDLE EAST AND AFRICA MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 23 MIDDLE EAST AND AFRICA MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 24 MIDDLE EAST AND AFRICA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE 2019-2027 (USD MILLION)

TABLE 25 MIDDLE EAST AND AFRICA SOFTWARE FOR DIABETES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 26 MIDDLE EAST AND AFRICA SOFTWARE FOR MENTAL HEALTH IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 27 MIDDLE EAST AND AFRICA SOFTWARE FOR RESPIRATORY CONDITIONS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 28 MIDDLE EAST AND AFRICA SOFTWARE FOR OPIOID USE DIOSRDER IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 29 MIDDLE EAST AND AFRICA OTHERS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 30 MIDDLE EAST AND AFRICA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES 2019-2027 (USD MILLION)

TABLE 31 MIDDLE EAST AND AFRICA BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 32 MIDDLE EAST AND AFRICA BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 33 MIDDLE EAST AND AFRICA MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 34 MIDDLE EAST AND AFRICA MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 35 MIDDLE EAST AND AFRICA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY 2019-2027 (USD MILLION)

TABLE 36 MIDDLE EAST AND AFRICA ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 37 MIDDLE EAST AND AFRICA ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2017-2027 (USD MILLION)

TABLE 38 MIDDLE EAST AND AFRICA IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 39 MIDDLE EAST AND AFRICA IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2017-2027 (USD MILLION)

TABLE 40 MIDDLE EAST AND AFRICA WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 41 MIDDLE EAST AND AFRICA WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2017-2027 (USD MILLION)

TABLE 42 MIDDLE EAST AND AFRICA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2019-2027 (USD MILLION)

TABLE 43 MIDDLE EAST AND AFRICA NATIVE APPS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 44 MIDDLE EAST AND AFRICA WEB APPS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 45 MIDDLE EAST AND AFRICA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2019-2027 (USD MILLION)

TABLE 46 MIDDLE EAST AND AFRICA METABOLIC CONDITIONS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 47 MIDDLE EAST AND AFRICA MAJOR DEPRESSIVE DISORDER IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 48 MIDDLE EAST AND AFRICA RESPIRATORY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 49 MIDDLE EAST AND AFRICA CARDIOVASCULAR IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 50 MIDDLE EAST AND AFRICA SUBSTANCE USE DISORDERS (SUD) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 51 MIDDLE EAST AND AFRICA OPIOID USE DISORDER IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 52 MIDDLE EAST AND AFRICA INSOMNIA IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 53 MIDDLE EAST AND AFRICA PAIN MANAGEMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 54 MIDDLE EAST AND AFRICA ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 55 MIDDLE EAST AND AFRICA MOVEMENT DISORDER IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 56 MIDDLE EAST AND AFRICA INFLAMMATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 57 MIDDLE EAST AND AFRICA ONCOLOGY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 58 MIDDLE EAST AND AFRICA MIGRAINE IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 59 MIDDLE EAST AND AFRICA ALZHEIMER’S DISEASE IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 60 MIDDLE EAST AND AFRICA EPILEPSY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 61 MIDDLE EAST AND AFRICA MULTIPLE SCLEROSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 62 MIDDLE EAST AND AFRICA AUTISM SPECTRUM DISORDERIN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 63 MIDDLE EAST AND AFRICA OTHER IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 64 MIDDLE EAST AND AFRICA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY PATIENTS 2019-2027 (USD MILLION)

TABLE 65 MIDDLE EAST AND AFRICA ADULTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 66 MIDDLE EAST AND AFRICA CHILDREN IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 67 MIDDLE EAST & AFRICA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY COUNTRY, 2018-2027 (USD MILLION)

TABLE 68 MIDDLE EAST & AFRICA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 69 MIDDLE EAST & AFRICA INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 70 MIDDLE EAST & AFRICA PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 71 MIDDLE EAST & AFRICA DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 72 MIDDLE EAST & AFRICA AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 73 MIDDLE EAST & AFRICA INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 74 MIDDLE EAST & AFRICA OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 75 MIDDLE EAST & AFRICA PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 76 MIDDLE EAST & AFRICA ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 77 MIDDLE EAST & AFRICA CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 78 MIDDLE EAST & AFRICA OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 79 MIDDLE EAST & AFRICA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)

TABLE 80 MIDDLE EAST & AFRICA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 81 MIDDLE EAST & AFRICA OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 82 MIDDLE EAST & AFRICA MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 83 MIDDLE EAST & AFRICA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)

TABLE 84 MIDDLE EAST & AFRICA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 85 MIDDLE EAST & AFRICA BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 86 MIDDLE EAST & AFRICA MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 87 MIDDLE EAST & AFRICA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 88 MIDDLE EAST & AFRICA ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 89 MIDDLE EAST & AFRICA IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 90 MIDDLE EAST & AFRICA WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 91 MIDDLE EAST & AFRICA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)

TABLE 92 MIDDLE EAST & AFRICA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 93 MIDDLE EAST & AFRICA PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)

TABLE 94 SAUDI ARABIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 95 SAUDI ARABIA INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 96 SAUDI ARABIA PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 97 SAUDI ARABIA DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 98 SAUDI ARABIA AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 99 SAUDI ARABIA INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 100 SAUDI ARABIA OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 101 SAUDI ARABIA PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 102 SAUDI ARABIA ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 103 SAUDI ARABIA CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 104 SAUDI ARABIA OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 105 SAUDI ARABIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)

TABLE 106 SAUDI ARABIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 107 SAUDI ARABIA OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 108 SAUDI ARABIA MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 109 SAUDI ARABIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)

TABLE 110 SAUDI ARABIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 111 SAUDI ARABIA BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 112 SAUDI ARABIA MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 113 SAUDI ARABIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 114 SAUDI ARABIA ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 115 SAUDI ARABIA IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 116 SAUDI ARABIA WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 117 SAUDI ARABIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)

TABLE 118 SAUDI ARABIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 119 SAUDI ARABIA PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)

TABLE 120 SOUTH AFRICA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 121 SOUTH AFRICA INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 122 SOUTH AFRICA PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 123 SOUTH AFRICA DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 124 SOUTH AFRICA AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 125 SOUTH AFRICA INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 126 SOUTH AFRICA OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 127 SOUTH AFRICA PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 128 SOUTH AFRICA ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 129 SOUTH AFRICA CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 130 SOUTH AFRICA OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 131 SOUTH AFRICA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)

TABLE 132 SOUTH AFRICA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 133 SOUTH AFRICA OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 134 SOUTH AFRICA MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 135 SOUTH AFRICA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)

TABLE 136 SOUTH AFRICA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 137 SOUTH AFRICA BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 138 SOUTH AFRICA MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 139 SOUTH AFRICA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 140 SOUTH AFRICA ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 141 SOUTH AFRICA IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 142 SOUTH AFRICA WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 143 SOUTH AFRICA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)

TABLE 144 SOUTH AFRICA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 145 SOUTH AFRICA PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)

TABLE 146 UAE PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 147 UAE INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 148 UAE PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 149 UAE DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 150 UAE AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 151 UAE INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 152 UAE OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 153 UAE PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 154 UAE ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 155 UAE CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 156 UAE OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 157 UAE PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)

TABLE 158 UAE PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 159 UAE OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 160 UAE MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 161 UAE PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)

TABLE 162 UAE PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 163 UAE BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 164 UAE MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 165 UAE PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 166 UAE ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 167 UAE IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 168 UAE WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 169 UAE PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)

TABLE 170 UAE PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 171 UAE PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)

TABLE 172 ISRAEL PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 173 ISRAEL INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 174 ISRAEL PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 175 ISRAEL DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 176 ISRAEL AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 177 ISRAEL INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 178 ISRAEL OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 179 ISRAEL PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 180 ISRAEL ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 181 ISRAEL CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 182 ISRAEL OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 183 ISRAEL PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)

TABLE 184 ISRAEL PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 185 ISRAEL OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 186 ISRAEL MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 187 ISRAEL PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)

TABLE 188 ISRAEL PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 189 ISRAEL BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 190 ISRAEL MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 191 ISRAEL PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 192 ISRAEL ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 193 ISRAEL IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 194 ISRAEL WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 195 ISRAEL PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)

TABLE 196 ISRAEL PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 197 ISRAEL PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)

TABLE 198 KUWAIT PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 199 KUWAIT INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 200 KUWAIT PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 201 KUWAIT DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 202 KUWAIT AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 203 KUWAIT INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 204 KUWAIT OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 205 KUWAIT PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 206 KUWAIT ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 207 KUWAIT CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 208 KUWAIT OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 209 KUWAIT PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)

TABLE 210 KUWAIT PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 211 KUWAIT OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 212 KUWAIT MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 213 KUWAIT PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)

TABLE 214 KUWAIT PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 215 KUWAIT BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 216 KUWAIT MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 217 KUWAIT PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 218 KUWAIT ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 219 KUWAIT IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 220 KUWAIT WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 221 KUWAIT PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)

TABLE 222 KUWAIT PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 223 KUWAIT PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)

TABLE 224 EGYPT PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 225 EGYPT INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 226 EGYPT PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 227 EGYPT DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 228 EGYPT AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 229 EGYPT INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 230 EGYPT OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 231 EGYPT PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 232 EGYPT ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 233 EGYPT CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 234 EGYPT OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 235 EGYPT PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)

TABLE 236 EGYPT PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 237 EGYPT OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 238 EGYPT MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 239 EGYPT PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)

TABLE 240 EGYPT PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 241 EGYPT BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 242 EGYPT MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 243 EGYPT PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 244 EGYPT ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 245 EGYPT IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 246 EGYPT WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 247 EGYPT PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)

TABLE 248 EGYPT PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 249 EGYPT PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)

TABLE 250 EGYPT PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

 

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions